Omron: Notice regarding the pricing for the secondary offering of the shares

Omron Corporation (hereinafter, the “Company”) announces that it has approved a resolution to price the secondary offering of shares of the common stock of the Company as set forth below at the meeting of the board of directors held on November 28, 2017. 1. Secondary Offering of Shares (Offering by way of Purchase and Subscription …

Omron Corporation (hereinafter, the “Company”) announces that it has approved a resolution to price the secondary offering of shares of the common stock of the Company as set forth below at the meeting of the board of directors held on November 28, 2017. 1.

Secondary Offering of Shares (Offering by way of Purchase and Subscription by the Underwriter) (1) Selling price per Share JPY6,343 per share (2) Aggregate Selling Price JPY18,236,125,000 (3) Underwriting Price per Share JPY6,081.40 per share (4) Aggregate Underwriting Price JPY17,484,025,000 (5) Delivery Date Tuesday, December 19, 2017 Note: The underwriter will underwrite the shares at the underwriting price and reoffer at the selling price.

2.Secondary Offering of Shares (Offering by way of Over-Allotment) (1) Number of Shares to be Offered 430,000 shares (2) Selling price per Share JPY6,343 per share (3) AggregateSelling Price JPY2,727,490,000 (4) Delivery Date Tuesday, December 19, 2017 Disclaimer: This Company Announcement has been prepared for the purpose of announcing an offering of shares, and not for the purpose of soliciting investment or engaging in any other similar activities within or outside Japan. This Company Announcement does not constitute or form a part of any offer to sell, offer to purchase, solicitation to sell or solicitation to purchase or subscribe for securities in any jurisdiction in which such offer or solicitation or sale would be unlawful. Securities may not be offered or sold within the United States or to U.S. persons absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended, and the rules and regulations thereunder. Any public offering of securities to be made in the United States will be made by means of a prospectus. Such prospectus will contain detailed information about the company making the offer and its management and financial statements. The Company does not intend to register any securities in the United States, and no public offering of securities will be made in the United States or in any other jurisdiction where such an offering is restricted or prohibited. There will be no public offering of the securities referred to above in the United States. 1.Method of determining the Selling Price (1) Determination date and price Monday, December 11, 2017 JPY6,540 (2) Discount ratio 3.01% 2.Exercise Period of the Green Shoe Option Tuesday, December 19, 2017 – Friday, December 22, 2017 3.Syndicate Covering Transaction Period Thursday, December 14, 2017 – Friday, December 22, 2017

www.steroid-pharm.com

np.com.ua

dmi.com.ua
Close
Close